(Q46799385)

English

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline Seynaeve

11

object named as

C Seynaeve

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

Maartje J. Hooning

6

object named as

M J Hooning

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

author name string

P M L H Vencken

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

M Kriege

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

D Hoogwerf

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

S Beugelink

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

M E L van der Burg

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

E M Berns

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

A Jager

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

M Collée

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

C W Burger

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

publication date

12 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

22

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

1346-1352

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

BRCA1 and implications for response to chemotherapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Hereditary ovarian cancer: biology, response to chemotherapy and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

A DGGE system for comprehensive mutation screening ofBRCA1andBRCA2: application in a Dutch cancer clinic setting

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Improved survival in BRCA2 carriers with ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Low-grade serous ovarian cancer: a unique disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Is It Time to Stratify for BRCA Mutation Status in Therapeutic Trials in Ovarian Cancer?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ628

21 January 2018

Identifiers

10.1093/ANNONC/MDQ628

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21228333

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46799385&oldid=2132745128"